Safety, Performance and Durability of the TIES® Implant in Patients Requiring a Permanent Ileostomy

NCT03416023 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-03-11

Study results available
· View outcomes & findings →

Summary

Study to assess the safety, performance and durability of the TIES® transcutaneous titanium implant in patients requiring a permanent ileostomy.

Conditions

  • Ileostomy - Stoma

Interventions

DEVICE

TIES® (Transcutaneous Implant Evacuation System)

Transcutaneous Implant Evacuation System

Sponsors & Collaborators

  • Devicia AB (now part of Veranex)

    collaborator UNKNOWN
  • Ostomycure AB

    lead INDUSTRY

Principal Investigators

  • Ludvig Linton, PhD · OstomyCure AS

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2023-11-15
Completion
2023-11-15

Countries

  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03416023 on ClinicalTrials.gov